Cargando…
Topical tacrolimus for the treatment of secondary lymphedema
Secondary lymphedema, a life-long complication of cancer treatment, currently has no cure. Lymphedema patients have decreased quality of life and recurrent infections with treatments limited to palliative measures. Accumulating evidence indicates that T cells play a key role in the pathology of lymp...
Autores principales: | Gardenier, Jason C., Kataru, Raghu P., Hespe, Geoffrey E., Savetsky, Ira L., Torrisi, Jeremy S., Nores, Gabriela D. García, Jowhar, Dawit K., Nitti, Matthew D., Schofield, Ryan C., Carlow, Dean C., Mehrara, Babak J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5309859/ https://www.ncbi.nlm.nih.gov/pubmed/28186091 http://dx.doi.org/10.1038/ncomms14345 |
Ejemplares similares
-
Abstract 1: Topical Tacrolimus for the Treatment of Lymphedema
por: Gardenier, Jason C., et al.
Publicado: (2017) -
Inhibition of Inflammation and iNOS Improves Lymphatic Function in Obesity
por: Torrisi, Jeremy S., et al.
Publicado: (2016) -
Th2 Cytokines Inhibit Lymphangiogenesis
por: Savetsky, Ira L., et al.
Publicado: (2015) -
CD4(+) T cells are activated in regional lymph nodes and migrate to skin to initiate lymphedema
por: García Nores, Gabriela D., et al.
Publicado: (2018) -
Exercise training improves obesity‐related lymphatic dysfunction
por: Hespe, Geoffrey E., et al.
Publicado: (2016)